Search

Displaying results 6411 - 6420 of 8575 in total
  1. Drug

    Evategrel

    go.drugbank.com/drugs/DB21691
    Experimental

    Evategrel has a monoisotopic molecular weight of 471.11 Da.

  2. Drug

    Lecufexor

    go.drugbank.com/drugs/DB21714
    Experimental

    Lecufexor has a monoisotopic molecular weight of 618.05 Da.

  3. Drug

    Matsupexole

    go.drugbank.com/drugs/DB21715
    Experimental

    Matsupexole has a monoisotopic molecular weight of 446.25 Da.

  4. Drug

    Balinatunfib

    go.drugbank.com/drugs/DB21728
    Investigational

    Balinatunfib has a monoisotopic molecular weight of 502.19 Da.

  5. Drug

    Rogocekib

    go.drugbank.com/drugs/DB21739
    Investigational

    Rogocekib has a monoisotopic molecular weight of 408.15 Da.

  6. Drug

    Inbakicept

    go.drugbank.com/drugs/DB16479
    Investigational

    [L50592] This combination product was approved by the FDA on April 22, 2024, for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without

  7. Drug

    CoviGlobulin

    go.drugbank.com/drugs/DB15747
    Experimental

    CoviGlobulin, a rabbit polyclonal antibody, was specifically designed as a potential therapy for COVID-19.

  8. Drug

    AT3022

    go.drugbank.com/drugs/DB05172
    Experimental

    AT3022, the Altea Therapeutics’s fentanyl citrate transdermal patch designed to provide safe and rapid management of moderate to severe chronic pain.

  9. Drug

    Sirukumab

    go.drugbank.com/drugs/DB11803
    Investigational

    Sirukumab has been used in trials studying the treatment and basic science of Giant Cell Arteritis and Arthritis, Rheumatoid.

  10. Drug

    AZD-5672

    go.drugbank.com/drugs/DB11804
    Investigational

    Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.